Form 8-K - Current report:
SEC Accession No. 0001558370-21-012303
Filing Date
2021-09-08
Accepted
2021-09-08 16:02:31
Documents
12
Period of Report
2021-09-02
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cann-20210902x8k.htm   iXBRL 8-K 47540
  Complete submission text file 0001558370-21-012303.txt   154953

Data Files

Seq Description Document Type Size
2 EX-101.SCH cann-20210902.xsd EX-101.SCH 3041
3 EX-101.LAB cann-20210902_lab.xml EX-101.LAB 13571
4 EX-101.PRE cann-20210902_pre.xml EX-101.PRE 8676
5 EXTRACTED XBRL INSTANCE DOCUMENT cann-20210902x8k_htm.xml XML 4083
Mailing Address 6565 EAST EVANS AVENUE DENVER CO 80224
Business Address 6565 EAST EVANS AVENUE DENVER CO 80224 303-759-1300
GENERAL CANNABIS CORP (Filer) CIK: 0001477009 (see all company filings)

EIN.: 208096131 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54457 | Film No.: 211242032
SIC: 2833 Medicinal Chemicals & Botanical Products